HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Statistical coassembly of glycine receptor alpha1 wildtype and the hyperekplexia mutant alpha1(P250T) in HEK 293 cells: impaired channel function is not dominant in the recombinant system.

Abstract
The mutant allele GLRA1 (P250T) of the glycine receptor alpha1 subunit gene underlies a dominant form of the human neurological disorder, hyperekplexia. The encoded substitution, residing within the short intracellular TM1-2 loop, leads to dramatically accelerated desensitization and reduced apparent ligand affinity. Here, dominant negative effects of the alpha1(P250T) subunit on receptor function were studied in a recombinant system. Coexpression of varying ratios of wildtype and mutant cDNA resulted in intermediate desensitization time constants and EC(50) values. The gradual transition of current response properties indicated random coassembly of receptor subunits. Different from the dominant trait of clinical hyperekplexia associated with GLRA1 (P250T), wildtype subunits dominated the functional properties of mixed receptor complexes in the recombinant system.
AuthorsHans-Georg Breitinger, Cord-Michael Becker
JournalNeuroscience letters (Neurosci Lett) Vol. 331 Issue 1 Pg. 21-4 (Oct 04 2002) ISSN: 0304-3940 [Print] Ireland
PMID12359314 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • GLRA1 protein, human
  • Protein Subunits
  • Receptors, Glycine
  • Recombinant Proteins
  • Glycine
Topics
  • Cell Line, Transformed
  • Electrophysiology
  • Glycine (pharmacology)
  • Humans
  • Kinetics
  • Models, Chemical
  • Mutation
  • Nervous System Diseases (genetics)
  • Patch-Clamp Techniques
  • Protein Subunits (biosynthesis, drug effects, genetics)
  • Receptors, Glycine (biosynthesis, genetics)
  • Recombinant Proteins (biosynthesis, genetics)
  • Reflex, Startle (genetics)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: